A carregar...
Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice
BACKGROUND: The non-selective opioid receptor antagonist, naltrexone (NAL), reduces alcohol (ethanol) consumption in animals and humans and is an approved medication for treating alcohol abuse disorders. Proopiomelanocortin (POMC)-derived melanocortin (MC) and opioid peptides are produced in the sam...
Na minha lista:
| Publicado no: | Alcohol Clin Exp Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4515169/ https://ncbi.nlm.nih.gov/pubmed/26108334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.12774 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|